Table 3.

Overall Summary of Injection Site Reactions for the Safety Population

Injection Site Reaction	Placebo (n = 85)	NDV-3A Vaccine (n = 89)	NDV-3 Vaccine (n = 14)	All Patients (n = 188)
Patients with at least 1 injection site reaction	72 (84.7%)	78 (87.6%)	10 (71.4%)	160 (85.1%)
Induration	25 (29.4%)	46 (51.7%)	0	71 (37.8%)
Pain	56 (65.9%)	70 (78.7%)	7 (50.0%)	133 (70.7%)
Redness	35 (41.2%)	45 (50.6%)	2 (14.3%)	82 (43.6%)
Swelling	28 (32.9%)	47 (52.8%)	2 (14.3%)	77 (41.0%)
Tenderness	64 (75.3%)	71 (79.8%)	10 (71.4%)	145 (77.1%)

A patient is counted once if the patient reported ≥1 events in each injection site reaction.